Skip to main content
. Author manuscript; available in PMC: 2023 Jan 18.
Published in final edited form as: J Am Coll Cardiol. 2022 Jan 18;79(2):101–112. doi: 10.1016/j.jacc.2021.10.041

Table 2.

Hazard Ratios (95% CI) of total and cause-specific mortality according to categories of total olive oil intake

Categories of olive oil intake
Never or <1
per month
>0–≤4.5 g/d
(>0 to ≤1 teaspoon)
>4.5–≤ 7 g/d
>1 teaspoon to ≤1/2
>7 g/d
(>1/2
P for trend HR (95% CI) for 5 g
increase in olive oil
TOTAL MORTALITY
NHS Mean total olive oil (g/d) 0 1.6 (± 1.1) 5.8 (±0.7) 14.0 (± 8.8)
 N° cases/ Person-years 10158/527,372 8266/603,179 1570/117,489 2774/238,877
 Age-adjusted model 1 1 (Ref.) 0.73 (0.71, 0.75) 0.71 (0.67, 0.75) 0.62 (0.59, 0.65) <0.001 0.90 (0.89, 0.91)
 Multivariable model 2 1 (Ref.) 0.86 (0.84, 0.89) 0.85 (0.81, 0.90) 0.79 (0.75, 0.82) <0.001 0.95 (0.94, 0.96)
 Multivariable model 3 1 (Ref.) 0.87 (0.84, 0.89) 0.86 (0.81, 0.91) 0.79 (0.75, 0.82) <0.001 0.95 (0.94, 0.96)
HPFS Mean total olive oil (g/d) 0 1.6 (±1.1) 5.7 (±0.7) 13.7 (±8.5)
 N° cases/ Person-years 6359/271540 5065/308471 998/57641 1654/102670
 Age-adjusted model 1 1 (Ref.) 0.77 (0.75, 0.80) 0.75 (0.70, 0.80) 0.68 (0.64, 0.71) <0.0001 0.91 (0.90, 0.93)
 Multivariable model 2 1 (Ref.) 0.91 (0.87, 0.94) 0.88 (0.82, 0.94) 0.84 (0.80, 0.89) <0.0001 0.96 (0.95, 0.98)
 Multivariable model 3 1 (Ref.) 0.92 (0.88, 0.95) 0.89 (0.83, 0.95) 0.86 (0.81, 0.91) <0.0001 0.97 (0.95, 0.98)
Pooled model 3 1 (Ref.) 0.88 (0.86, 0.90) 0.86 (0.82, 0.90) 0.81 (0.78, 0.84) <0.001 0.96 (0.95, 0.97)
CARDIOVASCULAR DISEASE MORTALITY
NHS  N° cases/ P-years 2263/527,372 1655/603,179 266/117,489 553/238,877
 Age-adjusted model 1 1 (Ref.) 0.70 (0.66, 0.75) 0.60 (0.53, 0.69) 0.64 (0.59, 0.71) <0.001 0.91 (0.89, 0.94)
 Multivariable model 2 1 (Ref.) 0.82 (0.76, 0.87) 0.73 (0.64, 0.83) 0.84 (0.77, 0.93) 0.002 0.98 (0.95, 1.01)
 Multivariable model 3 1 (Ref.) 0.83 (0.77, 0.88) 0.74 (0.65, 0.84) 0.85 (0.77, 0.94) 0.006 0.98 (0.95, 1.01)
HPFS  N° cases/ Person-years 1993/275615 1383/311810 269/58305 439/103761
 Age-adjusted model 1 1 (Ref.) 0.73 (0.68, 0.78) 0.71 (0.63, 0.81) 0.65 (0.59, 0.72) <0.0051 0.92 (0.89, 0.95)
 Multivariable model 2 1 (Ref.) 0.84 (0.78, 0.90) 0.82 (0.72, 0.94) 0.81 (0.72, 0.90) 0.0005 0.97 (0.94, 1.00)
 Multivariable model 3 1 (Ref.) 0.84 (0.78, 0.90) 0.81 (0.71, 0.93) 0.79 (0.71, 0.88) 0.0002 0.97 (0.94, 1.00)
Pooled model 3 1 (Ref.) 0.82 (0.78, 0.86) 0.77 (0.70, 0.84) 0.81 (0.75, 0.87) <.0001 0.97 (0.95, 0.99)
CANCER MORTALITY
NHS  N° cases/ P-years 2431/527,372 2033/603,179 450/117,489 794/238,877
 Age-adjusted model 1 1 (Ref.) 0.77 (0.73, 0.82) 0.88 (0.79, 0.97) 0.75 (0.69, 0.81) <0.001 0.95 (0.93, 0.98)
 Multivariable model 2 1 (Ref.) 0.84 (0.79, 0.89) 0.96 (0.87, 1.07) 0.84 (0.77, 0.91) 0.02 0.98 (0.95, 1.00)
 Multivariable model 3 1 (Ref.) 0.85 (0.80, 0.90) 0.98 (0.88, 1.09) 0.86 (0.78, 0.93) 0.09 0.98 (0.96, 1.01)
HPFS  N° cases/ P-years 1290/229084 1880/387235 258/59343 336/74094
 Age-adjusted model 1 1 (Ref.) 0.80 (0.75, 0.86) 0.82 (0.72, 0.93) 0.72 (0.64, 0.80) <0.0001 0.92 (0.89, 0.95)
 Multivariable model 2 1 (Ref.) 0.88 (0.82, 0.94) 0.90 (0.79, 1.03) 0.81 (0.72, 0.90) 0.002 0.95 (0.91, 0.98)
 Multivariable model 3 1 (Ref.) 0.89 (0.82, 0.95) 0.92 (0.81, 1.05) 0.83 (0.74, 0.93) 0.01 0.95 (0.92, 0.99)
Pooled model 3 1 (Ref.) 0.86 (0.82, 0.90) 0.94 (0.87, 1.02) 0.83 (0.78, 0.89) 0.001 0.97 (0.95, 0.99)
NEURODEGENERATIVE DISEASE MORTALITY
NHS  N° cases/ P-years 1901/527,372 1315/603,179 267/117,489 399/238,877
 Age-adjusted model 1 1 (Ref.) 0.63 (0.58, 0.67) 0.67 (0.59, 0.76) 0.51 (0.45, 0.56) <.0001 0.86 (0.83, 0.89)
 Multivariable model 2 1 (Ref.) 0.84 (0.78, 0.90) 0.89 (0.78, 1.01) 0.69 (0.62, 0.77) <.0001 0.92 (0.89, 0.95)
 Multivariable model 3 1 (Ref.) 0.82 (0.76, 0.88) 0.85 (0.74, 0.97) 0.66 (0.59, 0.74) <.0001 0.90 (0.87, 0.94)
HPFS  N° cases/ P-years 834/275027 653/310992 127/58189 196/103519
 Age-adjusted model 1 1 (Ref.) 0.77 (0.69, 0.85) 0.71 (0.59, 0.85) 0.59 (0.50, 0.69) <.00001 0.87 (0.82, 0.91)
 Multivariable model 2 1 (Ref.) 1.02 (0.92, 1.14) 0.94 (0.78, 1.14) 0.88 (0.75, 1.03) 0.07 0.95 (0.91, 1.00)
 Multivariable model 3 1 (Ref.) 1.03 (0.93, 1.15) 0.95 (0.79, 1.15) 0.89 (0.75, 1.05) 0.11 0.96 (0.92, 1.01)
Pooled model 3 1 (Ref.) 0.88 (0.83, 0.94) 0.88 (0.78, 0.98) 0.71 (0.64, 0.78) <.0001 0.92 (0.89, 0.94)
RESPIRATORY DISEASE MORTALITY
NHS  N° cases/ P-years 867/527,372 713/603,179 121/117,48 204/238,877
 Age-adjusted model 1 1 (Ref.) 0.77 (0.70, 0.86) 90.69 (0.57, 0.84) 0.59 (0.50, 0.68) <.0001 0.86 (0.82, 0.91)
 Multivariable model 2 1 (Ref.) 0.90 (0.81,0.99) 0.80 (0.66, 0.97) 0.73 (0.62, 0.85) 0.0001 0.91 (0.87, 0.96)
 Multivariable model 3 1 (Ref.) 0.95 (0.86, 1.05) 0.88 (0.72, 1.07) 0.80 (0.68, 0.95) 0.008 0.94 (0.89, 0.98)
HPFS  N° cases/ P-years 487/276475 386/312247 73/58426 118/103937
 Age-adjusted model 1 1 (Ref.) 0.82 (0.72, 0.94) 0.76 (0.59, 0.98) 0.70 (0.57, 0.85) 0.001 0.91 (0.85, 0.97)
 Multivariable model 2 1 (Ref.) 0.95 (0.83, 1.09) 0.87 (0.68, 1.12) 0.83 (0.67, 1.02) 0.07 0.95 (0.89, 1.01)
 Multivariable model 3 1 (Ref.) 0.97 (0.85, 1.12) 0.90 (0.70, 1.16) 0.88 (0.71, 1.09) 0.21 0.97 (0.91, 1.03)
Pooled model 3 1 (Ref.) 0.95 (0.87, 1.03) 0.88 (0.75, 1.03) 0.82 (0.72, 0.93) 0.002 0.94 (0.91, 0.98)

Results are expressed as Hazard Ratios (HR) and 95% Confidence Intervals (95% CI). Abbreviations: NHS, Nurses’ Health Study, HPFS, Health Professionals Follow-up Study. Model 2 was adjusted for age (years), ethnicity (white, non-white), Southern European/Mediterranean ancestry (yes, no), married (yes/no), living alone (yes/no), smoking status (never, former, current smoker 1-14 cigarettes per day, 15-24 cigarettes per day, or ≥ 25 cigarettes per day), alcohol intake (0, 0.1-4.9,5.0-9.9,10.0-14.9, and ≥ 15.0 g/d), physical activity (<3.0,3.0-8.9,9.0-17.9,18.0-26.9,≥27.00 metabolic equivalent task-h/week), family history of diabetes (yes/no), family history of myocardial infarction (yes/no), family history of cancer (yes/no), multivitamin use (yes/no), aspirin use (yes/no), history of hypertension (yes/no), history of hypercholesterolemia (yes/no), in women postmenopausal status and menopausal hormone use [premenopausal, postmenopausal (no, past, or current hormone use), total energy intake (kilocalories per day) and body mass index (calculated as weight in kilograms divides by height in meters squared). Model 3 was additionally adjusted for red meat, fruits and vegetables, nuts, soda, whole grains intake (in quintiles), and trans fat. Results were pooled using a pooled dataset and stratifying by cohort (sex) and time period.